Vir Biotechnology Stock Analysis

Vir Stock Analysis Notes

About 74.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.79. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vir Biotechnology has Price/Earnings To Growth (PEG) ratio of 1.14. The entity recorded a loss per share of 3.93. The firm had not issued any dividends in recent years. Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California. Vir Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 444 people. For more information please call George Scangos at 415 906 4324 or visit https://www.vir.bio.

Vir Biotechnology Investment Alerts

Vir Biotechnology Upcoming and Recent Events

Vir Largest EPS Surprises

View All Earnings Estimates

Vir Biotechnology Environmental, Social, and Governance (ESG) Scores

Vir Stock Institutional Investors

Note, although Vir Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vir Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 980.57 M.

Vir Profitablity

Management Efficiency

Vir Biotechnology has Return on Asset of (0.1941) % which means that on every $100 spent on assets, it lost $0.1941. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3658) %, meaning that it generated no profit with money invested by stockholders. Vir Biotechnology's management efficiency ratios could be used to measure how well Vir Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/25/2024, Return On Tangible Assets is likely to drop to -0.34. In addition to that, Return On Capital Employed is likely to drop to -0.41. At this time, Vir Biotechnology's Net Tangible Assets are relatively stable compared to the past year. As of 11/25/2024, Non Currrent Assets Other is likely to grow to about 19.8 M, while Non Current Assets Total are likely to drop slightly above 219 M.

Technical Drivers

As of the 25th of November, Vir Biotechnology has the Variance of 18.34, coefficient of variation of (2,858), and Risk Adjusted Performance of (0.02). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vir Biotechnology, as well as the relationship between them. Please validate Vir Biotechnology market risk adjusted performance and treynor ratio to decide if Vir Biotechnology is priced more or less accurately, providing market reflects its prevalent price of 7.12 per share. Given that Vir Biotechnology has information ratio of (0.07), we advise you to double-check Vir Biotechnology's current market performance to make sure the company can sustain itself at a future point.

Vir Biotechnology Price Movement Analysis

Vir Biotechnology Insider Trading Activities

Vir Biotechnology Outstanding Bonds

Vir Biotechnology Predictive Daily Indicators

Vir Biotechnology Corporate Filings

Vir Biotechnology Forecast Models

Vir Biotechnology's time-series forecasting models are one of many Vir Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vir Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vir Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vir shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vir Biotechnology. By using and applying Vir Stock analysis, traders can create a robust methodology for identifying Vir entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vir analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vir analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Vir Biotechnology stock analysis indicators help investors evaluate how Vir Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vir Biotechnology shares will generate the highest return on investment. By understating and applying Vir Biotechnology stock analysis, traders can identify Vir Biotechnology position entry and exit signals to maximize returns.

When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.